Your browser doesn't support javascript.
loading
Parkinson's disease and parkinsonism: Clinicopathological discrepancies on diagnosis in three patients.
Toyoshima, Yasuko; Takahashi, Hitoshi; Katada, Shinnichi; Kojima, Naoyuki; Tada, Mari; Tani, Takashi; Koike, Ryoko; Nozawa, Takanori; Aida, Izumi; Nakajima, Takashi; Onodera, Osamu; Kakita, Akiyoshi.
Afiliação
  • Toyoshima Y; Department of Neurology, Brain Disease Center, Agano Hospital, Agano, Japan.
  • Takahashi H; Departments of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Katada S; Department of Pathology and Laboratory Medicine, Niigata Neurosurgical Hospital, Niigata, Japan.
  • Kojima N; Department of Neurology, Kobari Hospital, Noda, Japan.
  • Tada M; Department of Neurology, Kobari Hospital, Noda, Japan.
  • Tani T; Departments of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Koike R; Department of Neurology, NHO Nishiniigata Chuo Hospital, Niigata, Japan.
  • Nozawa T; Department of Neurology, NHO Nishiniigata Chuo Hospital, Niigata, Japan.
  • Aida I; Departments of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Nakajima T; Department of Neurology, NHO Niigata National Hospital, Niigata, Japan.
  • Onodera O; Department of Neurology, NHO Niigata National Hospital, Niigata, Japan.
  • Kakita A; Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Neuropathology ; 41(6): 450-456, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34779072
ABSTRACT
Parkinson's disease (PD) is one of the most common neurodegenerative disorders. The cardinal neuropathological features of PD include selective and progressive loss of pigmented neurons in the substantia nigra, deficiencies in dopaminergic signaling in the striatum, and occurrence of phosphorylated α-synuclein-identified Lewy bodies in the nervous system. Parkinsonism, the clinical presentation of movement disorders seen in PD, is a feature shared commonly by other pathologically distinct neurodegenerative diseases, such as progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and multiple system atrophy (MSA). Consequently, it is sometimes difficult to distinguish PD from such parkinsonism-related neurological disorders. In addition, parkinsonism is not always a feature of certain neurodegenerative diseases, and it can sometimes develop as a result of various forms of drug intoxication or cerebrovascular disease. Here, we describe the clinicopathological features of three patients (cases 1, 2, and 3) diagnosed as having PSP, MSA, and PD, respectively, in each of whom the postmortem histopathological diagnosis differed from the final clinical diagnosis. Neuropathologically, they had suffered from coexistent disorders PD, MSA, and argyrophilic grain disease (case 1); PD (case 2); and vascular parkinsonism (case 3). The variety of patients showing features of parkinsonism underlines the importance of careful long-term follow up followed by postmortem neuropathological evaluation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Paralisia Supranuclear Progressiva / Atrofia de Múltiplos Sistemas / Transtornos Parkinsonianos / Degeneração Corticobasal Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Paralisia Supranuclear Progressiva / Atrofia de Múltiplos Sistemas / Transtornos Parkinsonianos / Degeneração Corticobasal Idioma: En Ano de publicação: 2021 Tipo de documento: Article